GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $398,000 | +15.0% | 9,035 | 0.0% | 0.04% | +7.9% |
| Q3 2021 | $346,000 | -12.4% | 9,035 | -9.1% | 0.04% | -13.6% |
| Q2 2021 | $395,000 | -43.5% | 9,935 | -49.2% | 0.04% | -51.1% |
| Q1 2021 | $699,000 | +88.9% | 19,570 | +94.6% | 0.09% | +73.1% |
| Q4 2020 | $370,000 | -30.7% | 10,058 | -29.0% | 0.05% | -42.9% |
| Q3 2020 | $534,000 | -16.2% | 14,174 | -9.2% | 0.09% | -22.9% |
| Q2 2020 | $637,000 | -11.2% | 15,609 | -17.6% | 0.12% | -31.8% |
| Q1 2020 | $717,000 | -26.3% | 18,937 | -8.5% | 0.17% | -4.9% |
| Q4 2019 | $973,000 | +8.1% | 20,695 | -1.9% | 0.18% | +6.4% |
| Q3 2019 | $900,000 | +17.8% | 21,094 | +10.5% | 0.17% | +5.6% |
| Q2 2019 | $764,000 | +3.0% | 19,089 | +7.4% | 0.16% | +2.5% |
| Q1 2019 | $742,000 | +3.8% | 17,775 | -4.9% | 0.16% | -10.7% |
| Q4 2018 | $715,000 | -33.6% | 18,696 | -30.3% | 0.18% | -21.7% |
| Q3 2018 | $1,077,000 | -7.8% | 26,809 | -7.4% | 0.23% | -8.5% |
| Q2 2018 | $1,168,000 | +7.4% | 28,959 | +3.9% | 0.25% | +30.0% |
| Q1 2018 | $1,088,000 | -57.9% | 27,869 | -61.8% | 0.19% | -67.4% |
| Q4 2017 | $2,587,000 | -6.1% | 72,935 | +7.5% | 0.58% | -30.1% |
| Q3 2017 | $2,754,000 | -8.8% | 67,825 | -3.2% | 0.83% | -6.0% |
| Q2 2017 | $3,021,000 | +2.1% | 70,079 | -0.1% | 0.89% | -0.3% |
| Q1 2017 | $2,958,000 | +7.2% | 70,181 | -2.1% | 0.89% | +2.9% |
| Q4 2016 | $2,760,000 | -20.0% | 71,669 | -10.4% | 0.86% | -20.4% |
| Q3 2016 | $3,452,000 | -6.3% | 80,032 | -5.9% | 1.09% | -7.2% |
| Q2 2016 | $3,685,000 | +13.8% | 85,026 | +6.4% | 1.17% | +15.5% |
| Q1 2016 | $3,239,000 | -5.6% | 79,880 | -6.0% | 1.01% | +1.7% |
| Q4 2015 | $3,430,000 | +7.3% | 85,001 | +2.2% | 1.00% | +6.6% |
| Q3 2015 | $3,198,000 | +4.3% | 83,185 | +13.1% | 0.94% | +12.1% |
| Q2 2015 | $3,065,000 | -10.2% | 73,567 | -0.5% | 0.83% | -4.4% |
| Q1 2015 | $3,414,000 | +256.4% | 73,972 | +229.9% | 0.87% | +163.4% |
| Q4 2014 | $958,000 | -3.7% | 22,420 | +3.6% | 0.33% | -27.4% |
| Q3 2014 | $995,000 | +10.8% | 21,637 | +28.7% | 0.46% | +8.8% |
| Q2 2014 | $898,000 | +39.2% | 16,809 | +39.1% | 0.42% | +30.5% |
| Q1 2014 | $645,000 | +153.9% | 12,088 | +153.7% | 0.32% | +146.9% |
| Q4 2013 | $254,000 | – | 4,765 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |